
NEWSFLOW
WH Smith (#SMWH) – notes 20 weeks to 14th Jan growth, though revenue -4% LFL versus 2019
- 2023-01-18 07:54:27
I will have a listen later to the quarterly call from GlaxoSmithKline (GSK) following its first quarter numbers today. The numbers were fine and specifically mentioned the good performance of its pharmaceutical business ahead of the proposed demerger in July. I wrote about all this a couple of months ago and my advice remains to stay a holder here and make a call whether to retain one or both on the demerger in a few months time. If only all investments were as straightforward as the last 15 months in GlaxoSmithKline. And talking about more complex investments brings us to WH Smith (SMWH)...